1
|
Shaffer A, Nigh N, Weisbaum D, Anderson A, Wszalek T, Sutton BP, Webb A, Damon B, Moussa I, Arnold PM. Cardiothoracic and Vascular Surgery Implant Compatibility With Ultrahigh Field Magnetic Resonance Imaging (4.7 Tesla and 7 Tesla). Am J Cardiol 2023; 201:239-246. [PMID: 37392607 DOI: 10.1016/j.amjcard.2023.05.062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/16/2023] [Revised: 05/23/2023] [Accepted: 05/31/2023] [Indexed: 07/03/2023]
Abstract
The use of 7 Tesla (T) magnetic resonance imaging (MRI) is expanding across medical specialties, particularly, clinical neurosciences and orthopedics. Investigational 7 T MRI has also been performed in cardiology. A limiting factor for expansion of the role of 7 T, irrespective of the body part being imaged, is the sparse testing of biomedical implant compatibility at field strengths >3 T. Implant compatibility can be tested following the American Society for Testing and Materials International guidelines. To assess the current state of cardiovascular implant safety at field strengths >3 T, a systematic search was performed using PubMed, Web of Science, and citation matching. Studies written in English that included at least 1 cardiovascular-related implant and at least 1 safety outcome (deflection angle, torque, or temperature change) were included. Data were extracted for the implant studied, implant composition, deflection angle, torque, and temperature change, and the American Society for Testing and Materials International standards were followed. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting guidelines for scoping reviews were followed. A total of 9 studies were included. A total of 34 cardiovascular-related implants tested ex vivo at 7 T and 91 implants tested ex vivo at 4.7 T were included. The implants included vascular grafts and conduits, vascular access ports, peripheral and coronary stents, caval filters, and artificial valves. A total of 2 grafts, 1 vascular access port, 2 vena cava filters, and 5 stents were identified as incompatible with the 7 T MRI. All incompatible stents were 40 mm in length. Based on the safety outcomes reported, we identify several implants that may be compatible with >3 T MRI. This scoping review seeks to concisely summarize all the cardiovascular-related implants tested for ultrahigh field MRI compatibility to date.
Collapse
Affiliation(s)
- Annabelle Shaffer
- Carle Illinois College of Medicine, University of Illinois Urbana Champaign, Urbana, Illinois
| | - Noah Nigh
- Carle Illinois College of Medicine, University of Illinois Urbana Champaign, Urbana, Illinois
| | - David Weisbaum
- Department of Neurosurgery, Carle Foundation Hospital, Urbana, Illinois
| | - Aaron Anderson
- Carle Illinois Advanced Imaging Center, Carle Foundation Hospital, Urbana, Illinois; Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
| | - Tracey Wszalek
- Carle Illinois Advanced Imaging Center, Carle Foundation Hospital, Urbana, Illinois; Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
| | - Bradley P Sutton
- Carle Illinois College of Medicine, University of Illinois Urbana Champaign, Urbana, Illinois; Carle Illinois Advanced Imaging Center, Carle Foundation Hospital, Urbana, Illinois; Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
| | - Andrew Webb
- Carle Illinois Advanced Imaging Center, Carle Foundation Hospital, Urbana, Illinois; Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands; Leiden University Medical Center, Leiden, The Netherlands
| | - Bruce Damon
- Carle Illinois Advanced Imaging Center, Carle Foundation Hospital, Urbana, Illinois; Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
| | - Issam Moussa
- Carle Illinois College of Medicine, University of Illinois Urbana Champaign, Urbana, Illinois; Heart and Vascular Institute, Carle Foundation Hospital, Urbana, Illinois
| | - Paul M Arnold
- Carle Illinois College of Medicine, University of Illinois Urbana Champaign, Urbana, Illinois; Department of Neurosurgery, Carle Foundation Hospital, Urbana, Illinois.
| |
Collapse
|
2
|
Abstract
Food and Drug Administration approval of 7T MR imaging allows ultrahigh-field neuroimaging to extend from the research realm into the clinical realm. Increased signal is clinically advantageous for smaller voxels and thereby high spatial resolution imaging, with additional advantages of increased tissue contrast. Susceptibility, time-of-flight signal, and blood oxygen level-dependent signal also have favorable clinical benefit from 7T. This article provides a survey of clinical cases showcasing some advantages of 7T.
Collapse
|
3
|
Winter L, Seifert F, Zilberti L, Murbach M, Ittermann B. MRI‐Related Heating of Implants and Devices: A Review. J Magn Reson Imaging 2020; 53:1646-1665. [DOI: 10.1002/jmri.27194] [Citation(s) in RCA: 35] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2019] [Revised: 04/29/2020] [Accepted: 04/30/2020] [Indexed: 12/11/2022] Open
Affiliation(s)
- Lukas Winter
- Physikalisch‐Technische Bundesanstalt (PTB) Braunschweig and Berlin Germany
| | - Frank Seifert
- Physikalisch‐Technische Bundesanstalt (PTB) Braunschweig and Berlin Germany
| | - Luca Zilberti
- Istituto Nazionale di Ricerca Metrologica Torino Italy
| | - Manuel Murbach
- ZMT Zurich MedTech AG Zurich Switzerland
- Institute for Molecular Instrumentation and Imaging (i3M) Universidad Politécnica de Valencia (UPV) Valencia Spain
| | - Bernd Ittermann
- Physikalisch‐Technische Bundesanstalt (PTB) Braunschweig and Berlin Germany
| |
Collapse
|